Clinical Trial Update: The Efficacy and Safety of 2.5 mg Chlorhexidine Gluconate Chip (PerioChip®) in Frequent Treatment Versus Routine Treatment in Therapy of Adult Chronic Periodontitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of the 2.5 mg chlorhexidine gluconate chip (PerioChip) with frequent treatment compared to routine treatment fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis

Drugs mentioned

• PerioChip (chlorhexidine gluconate chip)

Snippet

Sponsor: Dexcel Pharma Technologies Ltd. | Conditions: Generalized Adult Periodontitis | Phase 3 | Status: COMPLETED